Utilization and disparities in medication treatment for opioid use disorder among patients with comorbid opioid use disorder and chronic pain during the COVID-19 pandemic.  Perry A, Wheeler-Martin K, Hasin DS, Terlizzi K, Mannes ZL, Jent V, ...

Association Between Clinician-Level Factors and Patient Outcomes in Virtual and In-Person Outpatient Treatment for Substance Use Disorders: Multilevel Analysis.  Welsh JW, Sitar SI, Parks MJ, Patton SC, Braughton JE, Waller LA, Ngo QM. ...

Access challenges to opioid use disorder treatment among individuals experiencing homelessness: Voices from the streets.  Hsu M, Jung OS, Kwan LT, Jegede O, Martin B, Malhotra A, Suzuki J.  J Subst Use Addict Treat. 2023 Nov 18;157:209...

Dynamic changes in methadone utilisation for opioid use disorder treatment: a retrospective observational study during the COVID-19 pandemic.  Kennalley AL, Fanelli JL, Furst JA, Mynarski NJ, Jarvis MA, Nichols SD, McCall KL, Piper BJ. ...

Incidence and Determinants of COVID-19 in Patients Seeking Treatment for Substance Use Disorder: A Patient-Based Linkage Study.  Lana-Lander I, Muñoz-Galán R, Palacio-Vieira J, Majo-Roca X, Martínez-Carbonell E, Muga R, Colom J.  Eur Add...

Changes in opioid treatment programs and harm reduction provider services during the COVID-19 pandemic: Findings from 10 states.  Heidari O, Shah H, Bhagwat A, Ahmad NJ, Whaley S, Sherman SG, Morris M, Saloner B.  Psychol Serv. 2023 Oct ...